FDA
-
-
-
-
-
-
-
Clearmind gets DSMB approval to test CMND-100 in AUD patients
-
-
-
-
-
-
-
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
-
-
-
-
-
-
-
Clearmind Medicine completes Part A dosing in Phase I/II alcohol disorder trial
-
-
-
-
-
-
-
Clearmind Medicine evaluates psychedelic drug for FDA breakthrough status
-
-
-
-
-
-
-
Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial
-
-
-
-
-
-
-
Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results
-
-
-
-
-
-
-
Clearmind Medicine reports positive safety data from CMND-100 trial
-
330,739 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

